Daré Bioscience Inc (DARE) has released an update to notify the public and investors about its officers.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Lisa Walters-Hoffert, co-founder and CFO of Daré Bioscience, Inc., will retire and transition to a consultancy role, effective January 26, 2024. She will be compensated monthly and remain eligible for a 2023 performance bonus. Sabrina Martucci Johnson, CEO and President, will assume the role of principal financial officer, while MarDee Haring-Layton, promoted to Chief Accounting Officer, will be the principal accounting officer. John Fair, Chief Commercial Officer, will resign effective June 30, 2024, transitioning to part-time until then, with plans for future consulting services. Additionally, Daré Bioscience’s Board will reduce from eight to six members, with Dr. Blanchard and Dr. Ononye-Onyia stepping down but continuing as advisors without extra compensation.
For further insights into DARE corporate activity, check out TipRanks’ Insiders Trading Activity page.
